Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cardiac Pathophysiology

Background:

• Diastolic dysfunction involves complex molecular and structural changes in the heart muscle.
• The precise molecular mechanisms driving diastolic dysfunction progression are not fully understood.
• Core cardio-enriched transcription factors (TFs) are implicated in regulating cardiac remodeling and diastolic function.

Purpose of the Study:

• To review current findings on the role of specific transcription factors in cardiac diastolic dysfunction.
• To highlight the potential of these transcription factors as therapeutic targets.
• To emphasize the importance of new animal models for studying disease mechanisms.

Main Methods:

• Literature review of existing studies on transcription factors and diastolic dysfunction.
• Analysis of the roles of TBX5, GATA-4/6, SRF, MYOCD, NRF2, and PITX2.
• Discussion of findings from new animal models.

Main Results:

• Specific transcription factors (TBX5, GATA-4/6, SRF, MYOCD, NRF2, PITX2) play significant roles in cardiac diastolic function and dysfunction.
• These TFs regulate genes involved in both adaptive and maladaptive cardiac remodeling.
• Interactions and cross-talk between TFs are crucial in disease pathogenesis.

Conclusions:

• Transcription factors are critical regulators of diastolic function and dysfunction.
• Targeting these TFs offers promising avenues for novel therapeutic strategies.
• Further biomedical research is needed to elucidate TF interactions and develop effective treatments for diastolic dysfunction.